carbenoxolone sodium has been researched along with Diabetic Cardiomyopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, W; Bi, F; Hao, Y; Li, H; Liu, X; Xu, X; Yang, Q; Yang, R | 1 |
1 other study(ies) available for carbenoxolone sodium and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Involvement of amylin B-H2S-connexin 43 signaling pathway in vascular dysfunction and enhanced ischemia-reperfusion-induced myocardial injury in diabetic rats.
Topics: Amylin Receptor Agonists; Animals; Carbenoxolone; Connexin 43; Diabetic Angiopathies; Diabetic Cardiomyopathies; Disease Models, Animal; Hydrogen Sulfide; Islet Amyloid Polypeptide; Isolated Heart Preparation; Male; Mesenteric Arteries; Myocardial Reperfusion Injury; Myocardium; Rats, Wistar; Signal Transduction; Sulfides; Vasodilation | 2020 |